Skip to main navigation Skip to search Skip to main content

Squamous Cell Skin Cancer, Version 1.2022 Featured Updates to the NCCN Guidelines: Squamous Cell Skin Cancer, Version 1.2022

  • Chrysalyne D. Schmults
  • , Rachel Blitzblau
  • , Sumaira Z. Aasi
  • , Murad Alam
  • , James S. Andersen
  • , Brian C. Baumann
  • , Jeremy Bordeaux
  • , Pei Ling Chen
  • , Robert Chin
  • , Carlo M. Contreras
  • , Dominick DiMaio
  • , Jessica M. Donigan
  • , Jeffrey M. Farma
  • , Karthik Ghosh
  • , Roy C. Grekin
  • , Kelly Harms
  • , Alan L. Ho
  • , Ashley Holder
  • , John Nicholas Lukens
  • , Theresa Medina
  • Kishwer S. Nehal, Paul Nghiem, Soo Park, Tejesh Patel, Igor Puzanov, Jeffrey Scott, Aleksandar Sekulic, Ashok R. Shaha, Divya Srivastava, William Stebbins, Valencia Thomas, Yaohui G. Xu, Beth McCullough, Mary A. Dwyer, Mai Q. Nguyen
  • Dana-Farber/Brigham and Women's Cancer Center
  • Duke University
  • Stanford University
  • Northwestern University
  • City of Hope National Medical Center
  • Washington University St. Louis
  • Case Western Reserve University
  • University of South Florida
  • University of California at Los Angeles
  • Ohio State University
  • University of Nebraska Medical Center
  • University of Utah
  • Mayo Clinic
  • University of California at San Francisco
  • University of Michigan, Ann Arbor
  • Memorial Sloan-Kettering Cancer Center
  • University of Alabama at Birmingham
  • University of Pennsylvania
  • University of Colorado Anschutz Medical Campus
  • Seattle Cancer Care Alliance
  • University of California at San Diego
  • University of Tennessee Health Science Center
  • Roswell Park Cancer Institute
  • Johns Hopkins University
  • UT Southwestern Simmons Comprehensive Cancer Center
  • Vanderbilt University
  • University of Texas MD Anderson Cancer Center
  • University of Wisconsin-Madison
  • National Comprehensive Cancer Network

Research output: Contribution to journalArticlepeer-review

133 Scopus citations

Abstract

The NCCN Guidelines for Squamous Cell Skin Cancer provide recommendations for diagnostic workup, clinical stage, and treatment options for patients with cutaneous squamous cell carcinoma. The NCCN panel meets annually to discuss updates to the guidelines based on comments from panel members and the Institutional Review, as well as submissions from within NCCN and external organizations. These NCCN Guidelines Insights focus on the introduction of a new surgical recommendation terminology (peripheral and deep en face margin assessment), as well as recent updates on topical prophylaxis, immunotherapy for regional and metastatic disease, and radiation therapy.

Original languageEnglish
Pages (from-to)1382-1394
Number of pages13
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume19
Issue number12
DOIs
StatePublished - Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Carcinoma, Squamous Cell/diagnosis
  • Epithelial Cells
  • Humans
  • Immunotherapy
  • Skin Neoplasms/diagnosis

Fingerprint

Dive into the research topics of 'Squamous Cell Skin Cancer, Version 1.2022 Featured Updates to the NCCN Guidelines: Squamous Cell Skin Cancer, Version 1.2022'. Together they form a unique fingerprint.

Cite this